Approval · Notice of Compliance 24927 · 2021
ONUREG: Notice of Compliance 24927
Issued January 5, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24927
- Date
- January 5, 2021
- Company
- Celgene IncSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority
Products in this notice
Medicinal ingredients
- AZACITIDINE 300 MG per TAB
- AZACITIDINE 200 MG per TAB